An interventional study of PROTECT in Depression, sponsored by Weill Medical College of Cornell University. Completed at 2 sites in United States. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2018-05-03.
Sponsored by Weill Medical College of Cornell University · Not applicable, Interventional, and Health services research
There is no current elder abuse service that systematically assesses and provides services to address the mental health needs of older adult abuse victims. The proposed study will investigate the efficacy of a skill-based, mental health intervention to help treat elder abuse victims, bolster mental health outcomes, and improve detection of symptomatology in future screenings.
Despite increasing recognition of the epidemic of elder abuse, we continue to face barriers helping abuse victims access and use elder abuse resolution services. In addition, many victims suffer from concurrent mental health problems that prevent them from taking the necessary steps to protect themselves. The proposed study will introduce a tailored intervention, built on an evidence-based approach (Problem Solving Therapy), to be delivered through a sustainable mental health program embedded in elder abuse services. The proposed psychotherapy is a brief 8-session weekly intervention that combines problem-solving therapy, anxiety management, and psycho education developed specifically for this population by this team.
The objectives of the project are to: identify the mental health needs of elder abuse victims, provide the mental health treatment, assess the impact of the treatment, and facilitate conditions which will sustain the mental health program.
8,059 studies on the registry are indexed under Depression; 1,643 are open to participants now.
This study's enrollment of 63 is below the median of 84 across 6,722 interventional studies indexed under Depression.
Browse Depression studies →Weill Medical College of Cornell University is the lead sponsor of 867 studies on the registry; 160 are open to participants now.
Of its 119 completed or terminated interventional studies of FDA-regulated products, 91 (76%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Participants will receive a brief psychotherapy that builds on Problem Solving Therapy (PST)
Behavioral: PROTECT
8-session weekly psychotherapy intervention that combines problem-solving therapy, anxiety management and psycho education developed specifically for this population
Depression (Hamilton Depression Rating Scale)
To document effectiveness of PROTECT intervention in reducing depressive symptoms. Severity of depression will be assessed at baseline and 12 weeks using the Hamilton Depression Rating Scale as the primary measure.
Time frame: 12 weeks
Functioning (Behavioral Activation for Depression Scale)
To document effectiveness of PROTECT intervention in increasing quality of life, social interaction, and overall functioning. Severity will be assessed at baseline and 12 weeks using the Behavioral Activation for Depression Scale as the primary measure.
Time frame: 12 weeks
Service Utilization (specialized mistreatment and service outcome questionnaires)
To document effectiveness of PROTECT intervention in increasing clients' utilization of elder abuse services and subsequently reporting a reduction in abuse. Service utilization and severity of abuse will be assessed at baseline and 12 weeks using specialized mistreatment and service outcome questionnaires.
Time frame: 12 weeks
Plan to share: Undecided
No publications or documents are linked to this record.
This study is completed, as verified in Apr 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Weill Medical College of Cornell University